Biosimilars
Regulatory
Sandoz Canada Negotiated with Pan-Canadian Pharmaceutical Alliance (pCPA) to Launch
Shots: In Jul 2020, following the pCPA agreement Riximyo is now reimbursed through Limited Use as well as the Exceptional Access Program while funding will be done by Cancer Care […]readmore